Addiction

Psychedelic science in post-COVID-19 psychiatry

Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., & O’Keane, V. | Irish journal of psychological medicine | 19 Aug 2020

Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse

Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020

Psychedelics and Psychedelic-Assisted Psychotherapy

Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I. | American Journal of Psychiatry | 1 May 2020

A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats

Rodríguez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., ... & Carrera, I. | ACS Chemical Neuroscience | 24 April 2020

Psilocybin Therapeutic Research: The Present and Future Paradigm

Kargbo, R. B. | ACS Medicinal Chemistry Letters | 2 March 2020

A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses

Chi, T., & Gold, J. A. | Journal of the Neurological Sciences | 30 January 2020

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.

Garcia-Romeu, A., Davis, A. K., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Frontiers in psychiatry | 22 January 2020

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials.

Fuentes, J. J., Fonseca, F., Elices, M., Farre, M., & Torrens, M. | Frontiers in Psychiatry | 21 January 2020

Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Bershad, A. K., Preller, K. H., Lee, R., Keedy, S., Wren-Jarvis, J., Bremmer, M. P., & de Wit, H. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 20 December 2019

Neurotrophic mechanisms of psychedelic therapy

Corne, R., & Mongeau, R. | Biologie aujourd'hui | 12 December 2019

4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels

Abiero, A., Botanas, C. J., Custodio, R. J., Sayson, L. V., Kim, M., Lee, H. J. & Cheong, J. H. | Psychopharmacology | 11 December 2019

Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.

dos Santos, R. G., & Hallak, J. E. C. | Neuroscience & Biobehavioral Reviews | 3 December 2019

Searching for Treatments for Cocaine Use Disorder: The Quest Continues.

Brady, K. T. | American Journal of Psychiatry | 1 November 2019

Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada

Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. | Drug and alcohol review | 5 September 2019

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019

Psychedelic drugs-a new era in  psychiatry? 

Nutt, D. | Dialogues in clinical neuroscience | June 2019

Dimethyltryptamine: Endogenous Role and Therapeutic Potential.

Rodrigues, A. V., Almeida, F. J., & Vieira-Coelho, M. A. | Journal of psychoactive drugs | 25 April 2019

Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport

Coleman, J. A., Yang, D., Zhao, Z., Wen, P. C., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. | Nature | 24 April 2019

Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder

Brown, T. K., Noller, G. E., & Denenberg, J. O. | Journal of psychoactive drugs | 9 April 2019

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits.

Marton, S., González, B., Rodríguez, S., Miquel, E., Martínez-Palma, L., Pazos, M., ... & Scorza, C. | Frontiers in pharmacology | 5 March 2019